Precision medicine for advanced colorectal and gastroesophageal cancer

被引：0
|
作者：
Miguel Reyes, Jose [1 ]
机构：
[1] Clin Las Condes, Ctr Canc Maria Luisa Solari Falabella, Dept Oncol Med, Santiago, Chile
来源：
REVISTA MEDICA CLINICA LAS CONDES | 2022年 / 33卷 / 02期
关键词：
Esophageal Cancers; Gastric Cancer; Neoplasma; KRAS WILD-TYPE; OPEN-LABEL; 1ST-LINE TREATMENT; PHASE-III; FLUOROURACIL FAILURE; CONTINUOUS-INFUSION; 2ND-LINE TREATMENT; PLUS CHEMOTHERAPY; RANDOMIZED-TRIAL; GASTRIC-CANCER;
D O I：
10.1016/j.rmclc.2022.03.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Colorectal and gastroesophageal cancer have a global high incidence and a high mortality rate. Surgery persists as the only curative therapy for patients with early stages of both diseases. In those patients that are diagnosed with metastatic or unresectable cancer, or that become metastatic after locoregional treatment, chemotherapy has been the traditional therapy, with rather poor results in terms of survival or progression free survival. Precision medicine using molecular markers is changing this situation. Herein we review the most relevant aspects with regards to advances in the treatment of both diseases.
引用
收藏
页码：125 / 139
页数：15
相关论文
共 50 条
  • [31] Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer
    Dienstmann, Rodrigo
    Vermeulen, Louis
    Guinney, Justin
    Kopetz, Scott
    Tejpar, Sabine
    Tabernero, Josep
    NATURE REVIEWS CANCER, 2017, 17 (02) : 79 - 92
  • [32] Colorectal Cancer: Genetic Underpinning and Molecular Therapeutics for Precision Medicine
    Dosunmu, Gideon T.
    Shergill, Ardaman
    GENES, 2024, 15 (05)
  • [33] Clinical management of metastatic colorectal cancer in the era of precision medicine
    Ciardiello, Fortunato
    Ciardiello, Davide
    Martini, Giulia
    Napolitano, Stefania
    Tabernero, Josep
    Cervantes, Andres
    CA-A CANCER JOURNAL FOR CLINICIANS, 2022, 72 (04) : 372 - 401
  • [34] Hereditary Colorectal Cancer Syndromes: Molecular Genetics and Precision Medicine
    Chen, Liuxiang
    Ye, Liansong
    Hu, Bing
    BIOMEDICINES, 2022, 10 (12)
  • [35] Circulating tumor cells in colorectal cancer in the era of precision medicine
    Hu, Mingchao
    Wang, Zhili
    Wu, Zeen
    Ding, Pi
    Pei, Renjun
    Wang, Qiang
    Xing, Chungen
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2022, 100 (02): : 197 - 213
  • [36] Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer
    Rodrigo Dienstmann
    Louis Vermeulen
    Justin Guinney
    Scott Kopetz
    Sabine Tejpar
    Josep Tabernero
    Nature Reviews Cancer, 2017, 17 : 79 - 92
  • [37] Radiomics-Guided Precision Medicine Approaches for Colorectal Cancer
    Quraishi, Mohammed I.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [38] Precision oncology in metastatic colorectal cancer — from biology to medicine
    Federica Di Nicolantonio
    Pietro Paolo Vitiello
    Silvia Marsoni
    Salvatore Siena
    Josep Tabernero
    Livio Trusolino
    Rene Bernards
    Alberto Bardelli
    Nature Reviews Clinical Oncology, 2021, 18 : 506 - 525
  • [39] Systemic treatment for metastatic colorectal cancer in the era of precision medicine
    Sandhu, Jaideep
    Lavingia, Viraj
    Fakih, Marwan
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 119 (05) : 564 - 582
  • [40] Precision oncology in metastatic colorectal cancer - from biology to medicine
    Di Nicolantonio, Federica
    Vitiello, Pietro Paolo
    Marsoni, Silvia
    Siena, Salvatore
    Tabernero, Josep
    Trusolino, Livio
    Bernards, Rene
    Bardelli, Alberto
    NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (08) : 506 - 525
12345